These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 6921842)
1. It's not artificial blood--but can do the work of RBCs. Schwarz T RN (For Managers); 1982 Oct; 45(12):38-41. PubMed ID: 6921842 [No Abstract] [Full Text] [Related]
3. [Artificial oxygen carriers -- a critical analysis of current developments]. Dinkelmann S; Northoff H Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):47-54. PubMed ID: 12522731 [No Abstract] [Full Text] [Related]
4. Clinical experience with Fluosol-DA (20%) in the United States. Tremper KK; Levine EM; Waxman K Int Anesthesiol Clin; 1985; 23(1):185-97. PubMed ID: 3884514 [No Abstract] [Full Text] [Related]
5. Fluosol-DA as a red-cell substitute in acute anemia. N Engl J Med; 1986 Dec; 315(26):1677-8. PubMed ID: 3785341 [No Abstract] [Full Text] [Related]
6. Rationale for the clinical studies of anemia treated with the perfluorochemical emulsion: Fluosol DA 20%. Tremper KK Prog Clin Biol Res; 1983; 122():307-13. PubMed ID: 6348785 [No Abstract] [Full Text] [Related]
12. Current status of oxygen carriers ('blood substitutes'): 2006. Winslow RM Vox Sang; 2006 Aug; 91(2):102-10. PubMed ID: 16907870 [TBL] [Abstract][Full Text] [Related]
13. [Fluorocarbons and other artificial bloods]. Faber JC Bull Soc Sci Med Grand Duche Luxemb; 1986; 123(2):31-2. PubMed ID: 3802368 [No Abstract] [Full Text] [Related]
14. Perfluorochemical "red blood cell substitutes": the continued search for an indication. Tremper KK Anesthesiology; 2002 Dec; 97(6):1333-4. PubMed ID: 12459656 [No Abstract] [Full Text] [Related]
15. Which is the foreseeable clinical application of oxygen-carrying blood substitutes (fluorocarbons and hemoglobin solutions)? Which impact are they likely to have on the activity of blood services? Vox Sang; 1982 Feb; 42(2):97-109. PubMed ID: 7064434 [No Abstract] [Full Text] [Related]
16. [Microcirculatory indices in the experimental therapy of acute blood loss using a blood substitute--an oxygen carrier based on perfluorodecalin]. Matvienko VP; Gusenova FM; Afonin NI; Aprosin IuD; Sidliarov DP Gematol Transfuziol; 1983 Apr; 28(4):38-41. PubMed ID: 6852511 [No Abstract] [Full Text] [Related]
19. [Clinical application of fluorocarbon artificial blood in 10 cases (author's transl)]. Xiong RC Zhonghua Wai Ke Za Zhi; 1981 Apr; 19(4):213-5. PubMed ID: 7261781 [No Abstract] [Full Text] [Related]
20. Blood substitutes and oxygen therapeutics: an overview and current status. Jahr JS; Nesargi SB; Lewis K; Johnson C Am J Ther; 2002; 9(5):437-43. PubMed ID: 12237737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]